William D. Clark - Apr 4, 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Stock symbol
GNCA
Transactions as of
Apr 4, 2022
Transactions value $
-$4,905
Form type
4
Date filed
4/5/2022, 08:15 AM
Previous filing
Mar 17, 2022
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$4.91K -3.92K -1.05% $1.25 369K Apr 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.